Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2025 10:31 ET | Source: Grabar Law Office

Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); Treace Medical Concepts (NASDAQ: TMCI); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of...
October 24, 2025 08:44 ET | Source: Grabar Law Office

Important Notice to Long-Term Shareholders of CS Disco Inc. (NYSE: LAW); Five Below, Inc. (NASDAQ: FIVE); Humana Inc. (NYSE: HUM); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

PHILADELPHIA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- CS Disco Inc. (NYSE: LAW) – Securities Fraud Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
October 13, 2025 15:41 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Unicycive Therapeutics, Inc. Investors

LOS ANGELES, Oct. 13, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Unicycive Therapeutics, Inc., (“Unicycive” or the "Company") (NASDAQ: UNCY) investors off a class action on behalf of...
October 13, 2025 11:41 ET | Source: Bragar Eagel & Squire

UNICYCIVE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Unicycive to Contact the Firm Before the October 14th Deadline in the Filed Class Action Lawsuit

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Unicycive (UNCY) To Contact Him Directly To Discuss Their Options Before the October 14th...
October 12, 2025 08:52 ET | Source: Faruqi & Faruqi LLP

UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Unicycive To Contact Him Directly To Discuss Their Options If you suffered...
October 10, 2025 13:57 ET | Source: Bragar Eagel & Squire

UNICYCIVE REMINDER: Bragar Eagel & Squire, P.C. Urges Investor to Contact the Firm Before the October 14th Deadline

Unicycive allegedly overstated its readiness to meet FDA manufacturing standards for its OLC drug NDA for treating hyperphosphatemia.
October 09, 2025 15:32 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Unicycive Therapeutics, Inc. Investors

LOS ANGELES, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Unicycive Therapeutics, Inc., (“Unicycive” or the "Company") (NASDAQ: UNCY) investors off a class action on behalf of...
October 08, 2025 10:45 ET | Source: Faruqi & Faruqi LLP

UNCY DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Unicycive To Contact Him Directly To Discuss Their Options If you suffered...
October 08, 2025 08:44 ET | Source: Grabar Law Office

Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX): Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc....
October 07, 2025 09:31 ET | Source: Grabar Law Office

Important Notice to Long-Term Shareholders of Humana Inc. (NYSE: HUM); Jasper Therapeutics, Inc. (NASDAQ: JSPR); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and Vestis Corp. (NYSE: VSTS): Grabar Law Office is Investigating Claims on Your Behalf

PHILADELPHIA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Humana Inc. (NYSE: HUM): Grabar Law Office is investigating claims on behalf of shareholders of Humana Inc. (NYSE: HUM). The investigation concerns...